YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia ...Middle East

SHANGHAI, April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, announced promising interim clinical data from an investigator-initiated trial (IIT) of YOLT-101...

Read More Details
Finally We wish PressBee provided you with enough information of ( YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia )

Also on site :

• Reeves warned employment rights law has already led to hiring freeze and loss of business confidence
• Walmart Is Selling an 'Elegant' $142 Lancome Perfume for Only $43, and Shoppers Say It 'Makes Heads Turn'
• Syria group says military chief arrested in UAE